The investigators randomized 26 men with HHV-8 to receive 8 weeks of valganciclovir or placebo. Participants were selected on the basis of previous studies showing that these patients shed HHV-8 in ...

Oct. 12, 2005 (San Francisco) — A safe and effective way to prevent or reduce AIDS-related cancers may be to successfully suppress the etiologic agent responsible for their development. This is one of ...

Human herpesvirus 8 (HHV-8), the causal agent of Kaposi's sarcoma, is transmitted sexually among homosexual men, but little is known of its transmission among women. Although HHV-8 has been detected ...

Predictive value for engraftment and survival of total nucleated cell dose (TNC) as compared to CD34+ cell dose after autologous and allogeneic bone marrow transplant (BMT) for hematologic ...

Severe pulmonary hypertension constitutes a group of diseases characterized by complex, lumen-occluding vascular lesions that develop in genetically susceptible persons. The only viral infection ...

Human herpesvirus type 8 (HHV-8/KSHV) is recognized as the essential infectious agent responsible for Kaposi's sarcoma, body cavity B cell lymphoma and some forms of Castelman's disease, an atypical B ...

HAART influences the presenting characteristics and improves the outcome of patients (pts) with Hodgkin’s disease and HIV infection (HD-HIV) No significant financial relationships to disclose. This is ...

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all ...